One Step Malaria Antigen P.f(HRP-II) Rapid Test

SD Bioline Malaria Ag Pf/Pan Rapid Diagnostic Test (RDT) that detects HRP-II antigens was introduced in the above interventions for malaria diagnosis, while laboratory confirmation of suspected malaria cases was obtained by the examination of blood specimen sent to the National Malarial Reference Center (National School of Public Health, NMRC). RDT is a lateral flow test that can detect malaria antigens in a small amount of blood (5 μL) and is based on the immunochromatographic principles—capture of parasite antigen using monoclonal antibodies against a malaria antigen [7]. It is estimated that over 200 different RDTs are commercially available [8], while a number of over 74 million RDTs were distributed during 2011, 72% of them in Africa, 22% in Southeast Asia and 4% in Eastern Mediterranean [9]. However, information is limited in regards to the evaluation of the use and performance of RDTs in non-endemic areas [8]. As Greece had been malaria-free for over 35 years, current experience on light microscopy regarding malaria diagnosis is quite low. Therefore, the effectiveness of RDT was assessed in order to find out whether this diagnostic tool could be routinely used for the diagnosis of malaria in a non-endemic country. SD Bioline Malaria Ag Pf/Pan Rapid Diagnostic Test (RDT) that detects HRP-II antigens was introduced in the above interventions for malaria diagnosis, while laboratory confirmation of suspected malaria cases was obtained by the examination of blood specimen sent to the National Malarial Reference Center (National School of Public Health, NMRC). RDT is a lateral flow test that can detect malaria antigens in a small amount of blood (5 μL) and is based on the immunochromatographic principles—capture of parasite antigen using monoclonal antibodies against a malaria antigen [7]. It is estimated that over 200 different RDTs are commercially available [8], while a number of over 74 million RDTs were distributed during 2011, 72% of them in Africa, 22% in Southeast Asia and 4% in Eastern Mediterranean [9]. However, information is limited in regards to the evaluation of the use and performance of RDTs in non-endemic areas [8]. As Greece had been malaria-free for over 35 years, current experience on light microscopy regarding malaria diagnosis is quite low. Therefore, the effectiveness of RDT was assessed in order to find out whether this diagnostic tool could be routinely used for the diagnosis of malaria in a non-endemic country.SD Bioline Malaria Ag Pf/Pan Rapid Diagnostic Test (RDT) that detects HRP-II antigens was introduced in the above interventions for malaria diagnosis, while laboratory confirmation of suspected malaria cases was obtained by the examination of blood specimen sent to the National Malarial Reference Center (National School of Public Health, NMRC). RDT is a lateral flow test that can detect malaria antigens in a small amount of blood (5 μL) and is based on the immunochromatographic principles—capture of parasite antigen using monoclonal antibodies against a malaria antigen [7]. It is estimated that over 200 different RDTs are commercially available [8], while a number of over 74 million RDTs were distributed during 2011, 72% of them in Africa, 22% in Southeast Asia and 4% in Eastern Mediterranean [9]. However, information is limited in regards to the evaluation of the use and performance of RDTs in non-endemic areas [8]. As Greece had been malaria-free for over 35 years, current experience on light microscopy regarding malaria diagnosis is quite low. Therefore, the effectiveness of RDT was assessed in order to find out whether this diagnostic tool could be routinely used for the diagnosis of malaria in a non-endemic country. SD Bioline Malaria Ag Pf/Pan Rapid Diagnostic Test (RDT) that detects HRP-II antigens was introduced in the above interventions for malaria diagnosis, while laboratory confirmation of suspected malaria cases was obtained by the examination of blood specimen sent to the National Malarial Reference Center (National School of Public Health, NMRC). RDT is a lateral flow test that can detect malaria antigens in a small amount of blood (5 μL) and is based on the immunochromatographic principles—capture of parasite antigen using monoclonal antibodies against a malaria antigen [7]. It is estimated that over 200 different RDTs are commercially available [8], while a number of over 74 million RDTs were distributed during 2011, 72% of them in Africa, 22% in Southeast Asia and 4% in Eastern Mediterranean [9]. However, information is limited in regards to the evaluation of the use and performance of RDTs in non-endemic areas [8]. As Greece had been malaria-free for over 35 years, current experience on light microscopy regarding malaria diagnosis is quite low. Therefore, the effectiveness of RDT was assessed in order to find out whether this diagnostic tool could be routinely used for the diagnosis of malaria in a non-endemic country.